Putnam Biorevolution ETF (SYNB) Annual Income Statement (USD)
SYNB Quarterly Financials (USD)
Frequently Asked Questions About Putnam Biorevolution ETF (SYNB) Stock
Putnam Biorevolution ETF's (SYNB) last reported annual revenue was N/A.
Putnam Biorevolution ETF's (SYNB) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Putnam Biorevolution ETF's(SYNB) is not profitable as of its last reported annual financials.
The net profit margin for Putnam Biorevolution ETF's(SYNB) from its laster reported year is N/A
The return on equity (ROE) for Putnam Biorevolution ETF's(SYNB) from its last reported annual financials is : N/A
The return on assets (ROA) for Putnam Biorevolution ETF's(SYNB) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for Putnam Biorevolution ETF's(SYNB) from its last reported annual financials is : N/A
The Debt to Equity ratio for Putnam Biorevolution ETF's(SYNB) from its last reported annual financials is : N/A
The dividend yield for Putnam Biorevolution ETF's(SYNB) from its laster reported year is 0.06%
Putnam Biorevolution ETF's(SYNB) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SYNB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
